[HTML][HTML] Molecular characterization of extended-spectrum β-lactamases among clinical isolates of Escherichia coli & Klebsiella pneumoniae: a multi-centric study from …

V Gautam, A Thakur, M Sharma, A Singh… - Indian Journal of …, 2019 - journals.lww.com
Methods: Clinical isolates of E. coli and K. pneumoniae were collected from the All India
Institute of Medical Sciences (AIIMS), New Delhi; the Jawaharlal Institute of Postgraduate …

[PDF][PDF] Molecular characterization of extended-spectrum β-lactamases among clinical isolates of Escherichia coli & Klebsiella pneumoniae: A multi-centric study from …

V Gautam, A Thakur, M Sharma, A Singh… - Indian J Med …, 2019 - researchgate.net
Background & objectives: The increasing prevalence of extended-spectrum β-lactamases
(ESBLs) has abated therapeutic options worldwide. This study was undertaken to …

Molecular characterization of extended-spectrum β-lactamases among clinical isolates of Escherichia coli & Klebsiella pneumoniae: A multi-centric study from tertiary …

V Gautam, A Thakur, M Sharma… - Indian Journal of …, 2019 - search.ebscohost.com
Background & objectives: The increasing prevalence of extended-spectrum β-
lactamases (ESBLs) has abated therapeutic options worldwide. This study was undertaken …

[HTML][HTML] Molecular characterization of extended-spectrum β-lactamases among clinical isolates of Escherichia coli & Klebsiella pneumoniae: A multi-centric study from …

V Gautam, A Thakur, M Sharma, A Singh… - The Indian Journal of …, 2019 - ncbi.nlm.nih.gov
Methods: Clinical isolates of E. coli and K. pneumoniae were collected from the All India
Institute of Medical Sciences (AIIMS), New Delhi; the Jawaharlal Institute of Postgraduate …

Molecular characterization of extended-spectrum [beta]-lactamases among clinical isolates of Escherichia coli & Klebsiella pneumoniae: A multi-centric study from …

V Gautam, A Thakur, M Sharma, A Singh… - Indian Journal of …, 2019 - go.gale.com
Background & objectives: The increasing prevalence of extended-spectrum [sz]-lactamases
(ESBLs) has abated therapeutic options worldwide. This study was undertaken to …

Molecular characterization of extended-spectrum β-lactamases among clinical isolates of Escherichia coli & Klebsiella pneumoniae: a multi-centric study from tertiary …

G Vikas, T Anjana, S Megha, S Avinash… - Indian Journal of …, 2019 - cabdirect.org
Background & objectives: The increasing prevalence of extended-spectrum β-lactamases
(ESBLs) has abated therapeutic options worldwide. This study was undertaken to …

Molecular characterization of extended-spectrum β-lactamases among clinical isolates of Escherichia coli & Klebsiella pneumoniae: A multi-centric study from tertiary …

V Gautam, A Thakur, M Sharma… - The Indian journal …, 2019 - pubmed.ncbi.nlm.nih.gov
Background & objectives The increasing prevalence of extended-spectrum β-lactamases
(ESBLs) has abated therapeutic options worldwide. This study was undertaken to …

Molecular characterization of extended-spectrum β-lactamases among clinical isolates of Escherichia coli & Klebsiella pneumoniae: A multi-centric study from tertiary …

V Gautam, A Thakur, M Sharma, A Singh… - The Indian Journal of …, 2019 - europepmc.org
Methods Clinical isolates of E. coli and K. pneumoniae were collected from the All India
Institute of Medical Sciences (AIIMS), New Delhi; the Jawaharlal Institute of Postgraduate …

Molecular characterization of extended-spectrum β-lactamases among clinical isolates of Escherichia coli & Klebsiella pneumoniae: A multi-centric study from tertiary …

V Gautam, A Thakur, M Sharma… - The Indian Journal …, 2019 - search.proquest.com
Background & objectives: The increasing prevalence of extended-spectrum β-lactamases
(ESBLs) has abated therapeutic options worldwide. This study was undertaken to …

[PDF][PDF] Molecular characterization of extended-spectrum β-lactamases among clinical isolates of Escherichia coli & Klebsiella pneumoniae: A multi-centric study from …

V Gautam, A Thakur, M Sharma, A Singh… - Indian J Med …, 2019 - researchgate.net
Background & objectives: The increasing prevalence of extended-spectrum β-lactamases
(ESBLs) has abated therapeutic options worldwide. This study was undertaken to …